Henry Schein (HSIC) Competitors $64.73 -0.15 (-0.23%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$64.76 +0.03 (+0.05%) As of 10/8/2025 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HSIC vs. COO, IDXX, MASI, MMSI, AMN, AVNS, BRBR, NVST, WST, and OMIShould you be buying Henry Schein stock or one of its competitors? The main competitors of Henry Schein include Cooper Companies (COO), IDEXX Laboratories (IDXX), Masimo (MASI), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), AVANOS MEDICAL (AVNS), BellRing Brands (BRBR), Envista (NVST), West Pharmaceutical Services (WST), and Owens & Minor (OMI). Henry Schein vs. Its Competitors Cooper Companies IDEXX Laboratories Masimo Merit Medical Systems AMN Healthcare Services AVANOS MEDICAL BellRing Brands Envista West Pharmaceutical Services Owens & Minor Cooper Companies (NASDAQ:COO) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability. Do analysts recommend COO or HSIC? Cooper Companies presently has a consensus price target of $84.75, suggesting a potential upside of 20.62%. Henry Schein has a consensus price target of $76.67, suggesting a potential upside of 18.44%. Given Cooper Companies' stronger consensus rating and higher possible upside, research analysts plainly believe Cooper Companies is more favorable than Henry Schein.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cooper Companies 1 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.71Henry Schein 0 Sell rating(s) 8 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.38 Which has stronger valuation & earnings, COO or HSIC? Cooper Companies has higher earnings, but lower revenue than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCooper Companies$3.90B3.59$392.30M$2.0334.61Henry Schein$12.67B0.62$390M$3.1020.88 Which has more risk and volatility, COO or HSIC? Cooper Companies has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Does the media refer more to COO or HSIC? In the previous week, Cooper Companies had 10 more articles in the media than Henry Schein. MarketBeat recorded 11 mentions for Cooper Companies and 1 mentions for Henry Schein. Cooper Companies' average media sentiment score of 0.56 beat Henry Schein's score of 0.31 indicating that Cooper Companies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is COO or HSIC more profitable? Cooper Companies has a net margin of 10.08% compared to Henry Schein's net margin of 3.05%. Henry Schein's return on equity of 14.36% beat Cooper Companies' return on equity.Company Net Margins Return on Equity Return on Assets Cooper Companies10.08% 9.82% 6.54% Henry Schein 3.05%14.36%5.52% Do institutionals & insiders hold more shares of COO or HSIC? 24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 2.0% of Cooper Companies shares are held by insiders. Comparatively, 1.1% of Henry Schein shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryCooper Companies beats Henry Schein on 13 of the 17 factors compared between the two stocks. Get Henry Schein News Delivered to You Automatically Sign up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSIC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSIC vs. The Competition Export to ExcelMetricHenry ScheinMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.87B$17.59B$6.10B$10.55BDividend YieldN/A1.67%5.69%4.75%P/E Ratio20.8816.9785.4727.60Price / Sales0.622.31601.78232.87Price / Cash8.8512.9337.9261.55Price / Book2.003.1013.136.76Net Income$390M$472.95M$3.30B$275.88M7 Day Performance-1.97%0.67%4.29%2.81%1 Month Performance-4.32%-6.76%9.45%9.24%1 Year Performance-8.20%-11.82%86.64%35.42% Henry Schein Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSICHenry Schein3.9435 of 5 stars$64.73-0.2%$76.67+18.4%-7.5%$7.87B$12.67B20.8825,000Analyst ForecastCOOCooper Companies4.0187 of 5 stars$67.67+0.2%$86.64+28.0%-33.5%$13.43B$3.90B16.8016,000Analyst ForecastIDXXIDEXX Laboratories4.2298 of 5 stars$630.56-0.3%$649.44+3.0%+32.5%$50.58B$3.90B52.6411,000Positive NewsAnalyst ForecastMASIMasimo4.3556 of 5 stars$142.94+1.1%$194.60+36.1%+9.8%$7.68B$2.09B25.855,600Analyst DowngradeMMSIMerit Medical Systems4.6929 of 5 stars$80.86+0.8%$107.50+32.9%-12.5%$4.75B$1.36B22.917,400Analyst ForecastAMNAMN Healthcare Services4.186 of 5 stars$18.51-1.9%$23.25+25.6%-50.4%$723.18M$2.98B8.942,968Analyst ForecastAVNSAVANOS MEDICAL2.0948 of 5 stars$11.55-1.9%N/A-49.0%$546.16M$687.80M9.652,227Positive NewsBRBRBellRing Brands4.0998 of 5 stars$36.74-0.2%$64.80+76.4%-44.1%$4.64B$2.00B16.96380Analyst ForecastAnalyst RevisionNVSTEnvista3.7447 of 5 stars$20.22-0.7%$20.92+3.5%+13.1%$3.38B$2.51B23.6612,300Analyst ForecastWSTWest Pharmaceutical Services4.864 of 5 stars$260.04-0.6%$318.56+22.5%-6.5%$18.81B$2.89B37.5810,600Analyst ForecastOMIOwens & Minor4.527 of 5 stars$4.69-1.8%$7.63+62.8%-65.2%$368.45M$10.70B3.2723,200News CoverageAnalyst ForecastGap Down Related Companies and Tools Related Companies COO Competitors IDXX Competitors MASI Competitors MMSI Competitors AMN Competitors AVNS Competitors BRBR Competitors NVST Competitors WST Competitors OMI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSIC) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Henry Schein, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Henry Schein With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.